SCHEDULE: Nano Dimension Faces Merger Proposal from Tang Capital

Tang Capital Management proposes a merger with Nano Dimension, offering $1.60 per share in cash, and has acquired a 6.8% stake in the company.

Summary

• Tang Capital Management, LLC (TCM) and its affiliates (collectively, the Reporting Persons) have filed a Schedule 13D indicating beneficial ownership of 14,292,813 Ordinary Shares of Nano Dimension Ltd., representing 6.8% of the outstanding shares.
• The Reporting Persons acquired these shares for investment purposes using approximately $19.5 million of working capital from TCP, TCPI, TCP III, and TCP IV.
• On June 30, 2026, TCM submitted a merger proposal to Nano Dimension's Board of Directors, offering to acquire all outstanding shares for $1.60 per share in cash.
• The proposal is subject to limited confirmatory due diligence and the execution of a definitive merger agreement, with TCM aiming to finalize an agreement by the end of July 2026.
• TCM, along with its affiliate Concentra Biosciences, LLC, has experience in acquiring businesses in transition, having completed 9 such transactions totaling $1.2 billion in acquisition value over the past three years.
• The Reporting Persons intend to engage in discussions and negotiations with Nano Dimension regarding the merger proposal.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive development for shareholders due to the concrete cash offer and the experience of the proposing entity, though the finalization of the deal remains uncertain.

Positives

• Tang Capital Management, a significant shareholder, has made a cash offer of $1.60 per share, providing immediate liquidity to Nano Dimension shareholders.
• The offer is backed by available funds, and the proposing entity has a track record of successful acquisitions in transitionary businesses.
• The proposal aims for a swift closing, with a target of executing a definitive agreement by the end of July 2026, indicating a potential for a quick resolution for shareholders.
• The Reporting Persons hold a substantial 6.8% stake in Nano Dimension, demonstrating a significant commitment and belief in the company's potential, albeit under a new structure.

Negatives

• The merger proposal is contingent on limited confirmatory due diligence, which could uncover issues that prevent the deal from proceeding.
• There is no certainty that discussions will occur or that the merger will be successfully completed.
• The Reporting Persons reserve the right to modify their ownership stake, including acquiring more shares or disposing of their current holdings, based on ongoing evaluations and market conditions.

Risks

• The outcome of the proposed merger is uncertain, as it depends on negotiations, due diligence, and the execution of a definitive agreement.
• The Reporting Persons may change their plans regarding their investment in Nano Dimension, potentially impacting the stock price.
• The company's future strategic direction is subject to change based on the outcome of the merger discussions.

Future Outlook

The future outlook for Nano Dimension is heavily dependent on the outcome of the merger proposal from Tang Capital Management. If the merger proceeds, shareholders would receive $1.60 per share in cash. If the merger does not proceed, the Reporting Persons may adjust their investment strategy, which could involve acquiring more shares or disposing of their current holdings.

Management Comments

• "On behalf of Tang Capital Management, LLC, I am pleased to submit this proposal to effect a merger between Nano Dimension and an affiliate of Tang Capital whereby the shareholders of Nano Dimension would receive immediate cash proceeds of $1.60 per share."
• "Tang Capital, together with its wholly owned affiliate Concentra Biosciences, LLC, has extensive experience acquiring businesses in transition. In the past three years, we have closed 9 such transactions with a combined acquisition value of $1.2 billion."
• "Tang Capital, which currently owns 6.8% of the ordinary shares outstanding of Nano Dimension, has funds immediately available to execute this transaction."
• "We are prepared to move quickly, and our proposal is subject to only limited confirmatory due diligence."
• "With the Companys cooperation, we would be prepared to execute a definitive merger agreement before the end of July 2026."
• "We look forward to discussing our proposal with you further."

Industry Context

StockSavvy.ai notes that this filing represents a significant activist investor move within the advanced materials and electronics manufacturing sector. The proposed merger by Tang Capital Management, a known investment firm with a focus on such sectors, suggests a belief that Nano Dimension's current market valuation does not reflect its intrinsic value or potential, prompting an offer to take the company private.

Stakeholder Impact

• Shareholders: Potential for immediate cash proceeds of $1.60 per share if the merger is completed, providing liquidity and a defined exit.
• Employees: The future of employees will depend on the acquiring entity's plans post-merger; potential for integration challenges or restructuring.
• Creditors: The financial stability of the acquiring entity and the terms of the merger agreement will impact creditors.
• Suppliers: Business relationships may be reviewed or altered under new ownership.

Next Steps

• Discussions and negotiations between Tang Capital Management and Nano Dimension regarding the merger proposal.
• Limited confirmatory due diligence by Tang Capital Management.
• Potential execution of a definitive merger agreement by the end of July 2026.
• Possible modification of ownership stake by Reporting Persons based on ongoing evaluation.

Key Dates

Recommendation

The filing presents a clear cash offer that provides a potential exit for shareholders at a defined price. However, the deal is subject to due diligence and negotiation, meaning it is not guaranteed. Investors should hold their position to await further developments and the outcome of the proposed merger, rather than making immediate buy or sell decisions based on this preliminary proposal.

Keywords

Nano Dimension, Schedule 13D, Tang Capital Management, Merger Proposal, Acquisition, Tender Offer, Shareholder Value, Ordinary Shares, ADSs, Kevin Tang, Concentra Biosciences